Publications

Journal Article Ppublish 7 citations
Electronic publication date
May 4, 2011

View on Pubmed.gov 21537460 | View on doi.org 10.4239/wjd.v2....

Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology.

Search for publications in this journal World J Diabetes - 2(4):49-53

Abstract

Frequent concomitant manifestation of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) has been recently demonstrated by epidemiological studies. This might be due to functional similarities between β-cells and neurons, such as secretion on demand of highly specific molecules in a tightly controlled fashion. An additional similarity represents the age-related alteration of hyperphosphorylated tau in AD patients. Similarly, alterations have been identified in β-cells of T2DM patients. The islet amyloid polypeptide has been associated with β-cell apoptosis. As a consequence of increasing age, the accumulation of highly modified proteins together with decreased regenerative potential might lead to increasing rates of apoptosis. Moreover, reduction of β-cell replication capabilities results in reduction of β-cell mass in mammals, simultaneously with impaired glucose tolerance. The new challenge is to learn much more about age-related protein modifications. This can lead to new treatment strategies for reducing the incidence of T2DM and AD.

References

J Biol Chem. 1993 Oct 25;268(30):22265-8

Am J Physiol. 1992 Aug;263(2 Pt 1):E274-81

Science. 2007 Nov 2;318(5851):806-9

Diabetes Res Clin Pract. 1996 Aug;33(3):153-8

Cited by 7 citations (total)

Journal Article Research Support, N.I.H., Extramural

Role of calcium-independent phospholipase A(2)β in human pancreatic islet β-cell apoptosis.

Electronic publication date February 6, 2013

Search for publications in this journal Am J Physiol Endocrinol Metab

Xiaoyong Lei [...] Sasanka Ramanadham et al.

Death of β-cells due to apoptosis is an important contributor to β-cell dysfunction in both type 1 and type 2...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties